Galsulfase: enzyme-replacement therapy for mucopolysaccharidosis Type VI (Maroteaux––Lamy syndrome)

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.1, 2006-01, pp. : 9-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spinal Cord Compression in Maroteaux-Lamy Syndrome: Case Report and Review of the Literature with Effects of Enzyme Replacement Therapy

Pediatric Neurosurgery, Vol. 48, Iss. 3, 2012-12 ,pp. : 191-198

Karger

Access to resources Recommend Favorite

Neurosurgical Interventions in Children with Maroteaux-Lamy Syndrome

Pediatric Neurosurgery, Vol. 35, Iss. 1, 2001-07 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

Expensive drugs for rare disorders: to treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VI

By Schlander M. Beck M.

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1285-1293

Informa Healthcare

Access to resources Recommend Favorite

IgE-Mediated Hypersensitivity and Desensitisation with Recombinant Enzymes in Pompe Disease and Type I and Type VI Mucopolysaccharidosis

International Archives of Allergy and Immunology, Vol. 169, Iss. 3, 2016-05 ,pp. : 198-202

Karger

Access to resources Recommend Favorite

Thrombocytosis Associated with Enzyme Replacement Therapy in Gaucher Disease

Acta Haematologica, Vol. 108, Iss. 2, 2002-08 ,pp. : 94-96

Karger

Access to resources Recommend Favorite